...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: AACR 2019
Reply New Message
Prev Message Back To Forum Threaded View Next Message

"Bear,,,, can we assume this is the preamble or basis for the Pfizer + RVX combo trial which we expect to be started this quarter??..."

No, this AACR poster is for the prostate cancer program, not the pending breast cancer program.

BearDownAZ

3 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply